bile acid TGR5 signaling
Selected indexed studies
- Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy. (Am J Physiol Gastrointest Liver Physiol, 2020) [PMID:31984784]
- Hypothalamic bile acid-TGR5 signaling protects from obesity. (Cell Metab, 2021) [PMID:33887197]
- Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. (Nat Rev Gastroenterol Hepatol, 2018) [PMID:29018272]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy. (2020) pubmed
- Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. (2018) pubmed
- Hypothalamic bile acid-TGR5 signaling protects from obesity. (2021) pubmed
- Ileitis promotes MASLD progression via bile acid modulation and enhanced TGR5 signaling in ileal CD8(+) T cells. (2024) pubmed
- Gut microbiota regulates postprandial GLP-1 response via ileal bile acid-TGR5 signaling. (2023) pubmed
- Bile Acid Physiology. (2017) pubmed
- TGR5-mediated bile acid sensing controls glucose homeostasis. (2009) pubmed
- Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism. (2021) pubmed
- Molecular Physiology of Bile Acid Signaling in Health, Disease, and Aging. (2021) pubmed
- Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease. (2017) pubmed